Skip to main content

Opiates and Other Analgesics

  • Chapter
Drug and Alcohol Abuse

Part of the book series: Critical Issues in Psychiatry ((CIPS))

  • 44 Accesses

Abstract

This chapter is concerned with those pain-killing drugs (analgesics) that are most likely to be misused, ranging from propoxyphene (Darvon) through the synthetic, opiatelike drugs to the major opiates, including morphine and heroin. The generalizations made here apply to almost all prescription painkillers, with the possible exception of the newer prescription anti-inflammatory medications. The material will also be relevant to the newer opiate-type drugs, including the mixed agonist/antagonist butorphanol (Stadol or Borphanol), which is similar to buprenorphene and nalbuphene, as well as fentanyl (Sublimaze). Most of these newer medications have not yet met the test of time to determine their actual propensity to develop adverse reactions, including addiction.1,2

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Vandam, L. D. Butorphanol. New England Journal of Medicine 302: 381–384, 1980.

    Article  CAS  Google Scholar 

  2. Hayes, J. R. Gentanyl. California Society for Treatment of Alcoholism and Other Drug Dependence News 8: 3–5, 1981.

    Google Scholar 

  3. Berridge, V. Opium and the historical perspective. Lancet 2: 78–80, 1977.

    Article  PubMed  CAS  Google Scholar 

  4. Musto, D. F. The American Disease. Origins of Narcotic Control. New Haven, Conn.: Yale University Press, 1973.

    Google Scholar 

  5. Stimmel, B. Heroin Dependency: Medical, Economic, and Social Aspects. New York: Stratton Intercontinental Medical Book Corp., 1975.

    Google Scholar 

  6. Jaffe, J. H., & Martin, W. R. Opioid analgesics and antagonists. In A. F. Gilman, L. S. Goodman, & A. Gilman (Eds.), The Pharmacological Basis of Therapeutics (6th ed.). New York: Macmillan, 1980.

    Google Scholar 

  7. Koob, G. F., & Bloom, F. E. Behavioral effects of opioid peptides. British Medical Bulletin 39: 89–94, 1983.

    PubMed  CAS  Google Scholar 

  8. Marshal, B. E., & Wollman H. General anesthetics. In A. F. Gilman, L. S. Goodman, & A. Gilman (Eds.), The Pharmacological Basis of Therapeutics (6th ed.). New York: Macmillan, 1980.

    Google Scholar 

  9. Cohen, M. R., Cohen, R. M., Pickar, D., et ah Behavioural effects after high dose naloxone administration to normal volunteers. Lancet 2: 1110, 1981.

    Article  PubMed  CAS  Google Scholar 

  10. Bloom, F., Segal, D., Ling, N., et al. Endorphins: Profound behavioral effects in rats suggest new etiological factors in mental illness. Science 194: 630–632, 1976.

    Article  PubMed  CAS  Google Scholar 

  11. Stimmel, B. The socioeconomics of heroin dependency. New England Journal of Medicine 287: 1275–1280, 1972.

    Article  PubMed  CAS  Google Scholar 

  12. Zinberg, N. E., & Jacobson, R. C. The natural history of “chipping. ” American Journal of Psychiatry 133: 37–40, 1976.

    PubMed  CAS  Google Scholar 

  13. Caplovitz, D. The Working Addict. New York: The Graduate School and the University Center of the City University of New York, 1976.

    Google Scholar 

  14. Dess, W. J., & Cole, F. C. The medically evacuated Viet-Nam narcotic abuser: A follow- up rehabilitative study. Bulletin on Narcotics 24: 55–65, 1977.

    Google Scholar 

  15. Robins, L. N., Helzer, J. E., & Davis, D. H. Narcotic use in Southeast Asia and afterward. Archives of General Psychiatry 32: 955–961, 1975.

    Article  PubMed  CAS  Google Scholar 

  16. Wechsler, H., & Rohman, M. E. Patterns of drug use among New England college students. American Journal of Drug and Alcohol Abuse 8: 27–37, 1981.

    Article  PubMed  CAS  Google Scholar 

  17. Des Jarlais, D. C., & Uppal G. S. Heroin activity in New York City, 1970–1978. American Journal of Drug and Alcohol Abuse 7: 335–346, 1980.

    Article  PubMed  Google Scholar 

  18. Halikas, J. A., Darvish, H. S., & Rimmer, J. D. The black addict: 1. Methodology, chronology of addiction, and overview of the population. American Journal of Drug and Alcohol Abuse 3: 529–543, 1976.

    Article  PubMed  CAS  Google Scholar 

  19. Croughan, J. L., Miller, J. P., Wagelin, D., et al. Psychiatric illness in male and female narcotic addicts. Journal of Psychiatry 43: 225–228, 1982.

    CAS  Google Scholar 

  20. Langenauer, B. J., & Bowden, C. L. A follow-up study of narcotic addicts in the NARA program. American Journal of Psychiatry 128: 73–78, 1971.

    Google Scholar 

  21. O’Brien, C. P., Woody, G. E., & McLellan, A. T. Long-term consequences of opiate dependence. The New England Journal of Medicine 304: 1098–1099, 1981.

    Article  PubMed  Google Scholar 

  22. Vaillant, G. E. A 20-year follow-up of New York narcotic addicts. Archives of General Psychiatry 29: 237–241, 1973.

    Article  PubMed  CAS  Google Scholar 

  23. Snow, M. Maturing out of narcotic addiction in New York City. The International Journal of Addictions 8: 921–938, 1973.

    CAS  Google Scholar 

  24. Winick, C. The life cycle of the narcotic addict and of addiction. Bulletin on Narcotics 26:1–11, 1964.

    Google Scholar 

  25. Kandel, D. B. Longitudinal Research on Drug Use. New York: Halstead Press, 1978.

    Google Scholar 

  26. Simpson, D. D., & Lloyd, M. R. Alcohol use following treatment for drug addiction. Journal of Studies on Alcohol 42: 323–335, 1981.

    PubMed  CAS  Google Scholar 

  27. Croughan, J. L., Miller, J. P., Whitman, B. Y., & Schober, J. G. Alcoholism and alcohol dependence in narcotic addicts: A prospective study with a five-year follow-up. American Journal of Drug and Alcohol Abuse 8: 85–94, 1981.

    Article  PubMed  CAS  Google Scholar 

  28. McGlothlin, W. H., & Anglin, M. D. Shutting off methadone, costs and benefits. Archives of General Psychiatry 38: 885–892, 1981.

    Article  PubMed  CAS  Google Scholar 

  29. Lass, H. Most chronic pain patients misuse drugs, study shows. Hospital Tribune World Service 6: 2, 1976.

    Google Scholar 

  30. Jones, R. E. A study of 100 physician psychiatric inpatients. American Journal of Psychiatry 134: 1119–1122, 1977.

    PubMed  CAS  Google Scholar 

  31. Siegel, S., Hirison, R. E., Krank, M. D., & McCully, J. Heroin “overdose” death: Contribution of drug-associated environmental cues. Science 226: 436–437, 1982.

    Article  Google Scholar 

  32. Kaufman, R. E., & Levy, S. B. Overdose treatment. Addict folklore and medical reality. Journal of the American Medical Association 227: 411–413, 1974.

    Article  PubMed  CAS  Google Scholar 

  33. Greene, M. H., & DuPont, R. L. The treatment of acute heroin toxicity. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974.

    Google Scholar 

  34. Dimijian, G. G. Differential diagnosis of emergency drug reactions. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974.

    Google Scholar 

  35. Kleber, H. D. The treatment of acute heroin toxicity. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974.

    Google Scholar 

  36. Oppenheimer, E., Stimson, G. V., & Thorley, A. Seven-year follow-up of heroin addicts: Abstinence and continued use compared. British Medical Journal 2:627–630, 1979.

    Google Scholar 

  37. McLellan, A. T., Woody, G. E., & O’Brien, C. P. Development of psychiatric illness in drug abusers. New England Journal of Medicine 302: 1310–1314, 1979.

    Article  Google Scholar 

  38. Rousaville, B. J., Weissman, M. M., Crits-Christoph, K., Wilbur, C., & Kleber, H. Diagnosis and symptoms of depression in opiate addicts. Archives of General Psychiatry 39: 151–156, 1982.

    Article  Google Scholar 

  39. Dorus, W., & Senay, E. C. Depression, demographics, and drug abuse. American Journal of Psychiatry 237: 699–704, 1980.

    Google Scholar 

  40. Siegel, S. Evidence from rats that morphine tolerance is a learned response. Journal of Comparative Physiology and Psychology 89: 498–506, 1975.

    Article  CAS  Google Scholar 

  41. Shapira, J. Drug Abuse: A Guide for the Clinician. New York: American Elsevier, 1975.

    Google Scholar 

  42. Cohen, S. (Ed.). The drug schedules: An updating for professionals. Drug Abuse and Alcoholism Newsletter 5. San Diego: Vista Hill Foundation, Apr. 1976.

    Google Scholar 

  43. Dole, V. P. Management of the opiate abstinence. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974.

    Google Scholar 

  44. Sorenson, J. L., Hargreaves, W. A., & Weinberg, J. A. Withdrawal from heroin in three or six weeks. Archives of General Psychiatry 39: 167–171, 1982.

    Article  Google Scholar 

  45. Tennant, F. S., & Uelmen, G. F. Prescribing narcotics to habitual and addicted narcotic users: Medical and legal guidelines in California and some other western states (medicine and the law). Western Journal of Medicine 233: 539–545, 1980.

    Google Scholar 

  46. Tennant, F. S., Russell, B. A., Casas, S. K., et al. Heroin detoxification. A comparison of propoxyphene and methadone. Journal of the American Medical Association 232: 1019–1022, 1975.

    Article  PubMed  Google Scholar 

  47. Jasinski, D. R., Pevnick, J. S., Clark, S. C., & Griffith, J. D. Therapeutic usefulness of propoxyphene napsylate in narcotic addiction. Archives of General Psychiatry 34: 227–233, 1977.

    Article  PubMed  CAS  Google Scholar 

  48. Frartz, D. N., Hare, B. D., & McCloskey K. L. Spinal sympathetic neurons: Possible sites of opiate-withdrawal suppression by Clonidine. Science 225: 1643–1645, 1982.

    Google Scholar 

  49. Charney, D. S., Riordan, C. E., Kleber, H. D., et al A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy. Archives of General Psychiatry 39: 1327–1332, 1982.

    Article  PubMed  CAS  Google Scholar 

  50. Gold, M. S., Pottash, A. C., & Kleber, H. D. Outpatient Clonidine detoxification. Lancet 2: 621, 1981.

    Article  Google Scholar 

  51. Charney, D. S., Sternberg, D. E., Kleber, H. D., Heninger, G. R., & Redmond, D. E. The clinical use of Clonidine in abrupt withdrawal from methadone. Archives of General Psychiatry 38: 1273–1277, 1981.

    Article  PubMed  CAS  Google Scholar 

  52. Jasinski, D. R., Johnson, R. E., & Makhxoumi, H. Efficacy of Clonidine in morphine withdrawal. Presented at the 20th Annual ACNP in San Diego, December 16–18, 1981.

    Google Scholar 

  53. Clement-Jones, V., Tomlin, S., Rees, L. H., McLoughlin, L., Besser, G. M., & Wen, H. L. Increased β-endorphin but no metenkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain. Lancet 2: 946–948, 1980.

    Article  PubMed  CAS  Google Scholar 

  54. Sheffet, A., Quinones, M., Levenhar, M. A., et al. An evaluation of detoxification as an initial step in the treatment of heroin addiction. American Journal of Psychiatry 133: 337–340, 1976.

    PubMed  CAS  Google Scholar 

  55. Green, M., & Suffet, F. The neonatal narcotic withdrawal index: A device for the im–provement of care in the abstinence syndrome. American Journal of Drug and Alcohol Abuse 8: 203–213, 1981.

    Article  PubMed  CAS  Google Scholar 

  56. Hoder, E. L., Leckman, J. F., Ehrenkranz, R., Kleber, H., Cohen, D. J., & Poulsen J. A. Clonidine in neonatal narcotic-abstinence syndrome. New England Journal of Medicine 305: 1284, 1981.

    PubMed  CAS  Google Scholar 

  57. Strass, M. E., Andresko, M., Stryker, J. C., et al. Relationship of neonatal withdrawal to maternal methadone dose. American Journal of Drug and Alcohol Abuse 3: 339–345, 1976.

    Article  Google Scholar 

  58. Reddy, A. M. The management of the narcotic withdrawal syndrome in the neonate. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974.

    Google Scholar 

  59. Cherubin, C. E. Management of acute medical complications resulting from heroin addiction. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974.

    Google Scholar 

  60. Wolters, E., Stam, F. C., Lousberg, R. J., et al. Leucoencephalopathy after inhaling “heroin” pyrolysate. Lancet 2: 1233–1238, 1982.

    Article  PubMed  CAS  Google Scholar 

  61. Mendelson, J. H., Mendelson, J. E., & Patch, V. D. Plasma testosterone levels in heroin addiction and during methadone maintenance. The Journal of Pharmacology and Experimental Therapeutics 192: 211–217, 1975.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

Schuckit, M.A. (1984). Opiates and Other Analgesics. In: Drug and Alcohol Abuse. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1176-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-1176-8_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-1178-2

  • Online ISBN: 978-1-4684-1176-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics